Loading…
Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses
HIV-1 envelope (Env) trimers, stabilized in a prefusion-closed conformation, can elicit humoral responses capable of neutralizing HIV-1 strains closely matched in sequence to the immunizing strain. One strategy to increase elicited neutralization breadth involves vaccine priming of immune responses...
Saved in:
Published in: | Journal of virology 2020-06, Vol.94 (13) |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c411t-9eb505d93198be1fe106026eb9cae8213290b1fc90a4badeb7d772df33f436703 |
---|---|
cites | cdi_FETCH-LOGICAL-c411t-9eb505d93198be1fe106026eb9cae8213290b1fc90a4badeb7d772df33f436703 |
container_end_page | |
container_issue | 13 |
container_start_page | |
container_title | Journal of virology |
container_volume | 94 |
creator | Chuang, Gwo-Yu Lai, Yen-Ting Boyington, Jeffrey C Cheng, Cheng Geng, Hui Narpala, Sandeep Rawi, Reda Schmidt, Stephen D Tsybovsky, Yaroslav Verardi, Raffaello Xu, Kai Yang, Yongping Zhang, Baoshan Chambers, Michael Changela, Anita Corrigan, Angela R Kong, Rui Olia, Adam S Ou, Li Sarfo, Edward K Wang, Shuishu Wu, Winston Doria-Rose, Nicole A McDermott, Adrian B Mascola, John R Kwong, Peter D |
description | HIV-1 envelope (Env) trimers, stabilized in a prefusion-closed conformation, can elicit humoral responses capable of neutralizing HIV-1 strains closely matched in sequence to the immunizing strain. One strategy to increase elicited neutralization breadth involves vaccine priming of immune responses against a target site of vulnerability, followed by vaccine boosting of these responses with prefusion-closed Env trimers. This strategy has succeeded at the fusion peptide (FP) site of vulnerability in eliciting cross-clade neutralizing responses in standard vaccine-test animals. However, the breadth and potency of the elicited responses have been less than optimal. Here, we identify three mutations (3mut), Met302, Leu320, and Pro329, that stabilize the apex of the Env trimer in a prefusion-closed conformation and show antigenically, structurally, and immunogenically that combining 3mut with other approaches (e.g., repair and stabilize and glycine-helix breaking) yields well-behaved clade C-Env trimers capable of boosting the breadth of FP-directed responses. Crystal structures of these trimers confirmed prefusion-closed apexes stabilized by hydrophobic patches contributed by Met302 and Leu320, with Pro329 assuming canonically restricted dihedral angles. We substituted the N-terminal eight residues of FP (FP8, residues 512 to 519) of these trimers with the second most prevalent FP8 sequence (FP8v2, AVGLGAVF) and observed a 3mut-stabilized consensus clade C-Env trimer with FP8v2 to boost the breadth elicited in guinea pigs of FP-directed responses induced by immunogens containing the most prevalent FP8 sequence (FP8v1, AVGIGAVF). Overall, 3mut can stabilize the Env trimer apex, and the resultant apex-stabilized Env trimers can be used to expand the neutralization breadth elicited against the FP site of vulnerability.
A major hurdle to the development of an effective HIV-1 vaccine is the elicitation of serum responses capable of neutralizing circulating strains of HIV, which are extraordinarily diverse in sequence and often highly neutralization resistant. Recently, we showed how sera with 20 to 30% neutralization breadth could, nevertheless, be elicited in standard vaccine test animals by priming with the most prevalent N-terminal 8 residues of the HIV-1 fusion peptide (FP8), followed by boosting with a stabilized BG505-envelope (Env) trimer. Here, we show that subsequent boosting with a 3mut-apex-stabilized consensus C-Env trimer, modified to have the second mo |
doi_str_mv | 10.1128/JVI.00074-20 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7307166</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2390647021</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-9eb505d93198be1fe106026eb9cae8213290b1fc90a4badeb7d772df33f436703</originalsourceid><addsrcrecordid>eNpVkctuFDEQRS0EIsPAjjXykkUcyna_vEHKY0IGhYdgMrCz3O5qxqjHbtruKOR_8p_0JCGCVUlVR7du1SXkJYcDzkX15v16eQAAZcYEPCIzDqpiec6zx2QGIATLZfV9jzyL8ScAz7Iie0r2pBAqV1DNyM0JXmIX-i36RENLDZUfxsQOe7xiX5OpXeeusaELf0shXQ1uiwNdbUyii6ve-CbSs-WacfoRxzSYCTfJBU-PBjRN2tBvG_T0Ik4aq0CPQoiJno5xR3zGPrkG2Ykb0KYJWBtrnUe26Jx1u8YXjH3wEeNz8qQ1XcQX93VOLk4Xq-Mzdv7p3fL48JzZjPPEFNY55I2SXFU18hY5FCAKrJU1WAkuhYKat1aByWrTYF02ZSmaVso2k0UJck7e3un2Y73Fxk5PmU7S_XS0GX7rYJz-f-LdRv8Il7qUUPKimARe3wsM4deIMemtixa7zngMY9RCKiiyEiYvc7J_h9ohxDhg-7CGg94lq6dk9W2yWuysvfrX2gP8N0r5Bw4aoYc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2390647021</pqid></control><display><type>article</type><title>Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses</title><source>Open Access: PubMed Central</source><source>American Society for Microbiology Journals</source><creator>Chuang, Gwo-Yu ; Lai, Yen-Ting ; Boyington, Jeffrey C ; Cheng, Cheng ; Geng, Hui ; Narpala, Sandeep ; Rawi, Reda ; Schmidt, Stephen D ; Tsybovsky, Yaroslav ; Verardi, Raffaello ; Xu, Kai ; Yang, Yongping ; Zhang, Baoshan ; Chambers, Michael ; Changela, Anita ; Corrigan, Angela R ; Kong, Rui ; Olia, Adam S ; Ou, Li ; Sarfo, Edward K ; Wang, Shuishu ; Wu, Winston ; Doria-Rose, Nicole A ; McDermott, Adrian B ; Mascola, John R ; Kwong, Peter D</creator><contributor>Silvestri, Guido</contributor><creatorcontrib>Chuang, Gwo-Yu ; Lai, Yen-Ting ; Boyington, Jeffrey C ; Cheng, Cheng ; Geng, Hui ; Narpala, Sandeep ; Rawi, Reda ; Schmidt, Stephen D ; Tsybovsky, Yaroslav ; Verardi, Raffaello ; Xu, Kai ; Yang, Yongping ; Zhang, Baoshan ; Chambers, Michael ; Changela, Anita ; Corrigan, Angela R ; Kong, Rui ; Olia, Adam S ; Ou, Li ; Sarfo, Edward K ; Wang, Shuishu ; Wu, Winston ; Doria-Rose, Nicole A ; McDermott, Adrian B ; Mascola, John R ; Kwong, Peter D ; Silvestri, Guido</creatorcontrib><description>HIV-1 envelope (Env) trimers, stabilized in a prefusion-closed conformation, can elicit humoral responses capable of neutralizing HIV-1 strains closely matched in sequence to the immunizing strain. One strategy to increase elicited neutralization breadth involves vaccine priming of immune responses against a target site of vulnerability, followed by vaccine boosting of these responses with prefusion-closed Env trimers. This strategy has succeeded at the fusion peptide (FP) site of vulnerability in eliciting cross-clade neutralizing responses in standard vaccine-test animals. However, the breadth and potency of the elicited responses have been less than optimal. Here, we identify three mutations (3mut), Met302, Leu320, and Pro329, that stabilize the apex of the Env trimer in a prefusion-closed conformation and show antigenically, structurally, and immunogenically that combining 3mut with other approaches (e.g., repair and stabilize and glycine-helix breaking) yields well-behaved clade C-Env trimers capable of boosting the breadth of FP-directed responses. Crystal structures of these trimers confirmed prefusion-closed apexes stabilized by hydrophobic patches contributed by Met302 and Leu320, with Pro329 assuming canonically restricted dihedral angles. We substituted the N-terminal eight residues of FP (FP8, residues 512 to 519) of these trimers with the second most prevalent FP8 sequence (FP8v2, AVGLGAVF) and observed a 3mut-stabilized consensus clade C-Env trimer with FP8v2 to boost the breadth elicited in guinea pigs of FP-directed responses induced by immunogens containing the most prevalent FP8 sequence (FP8v1, AVGIGAVF). Overall, 3mut can stabilize the Env trimer apex, and the resultant apex-stabilized Env trimers can be used to expand the neutralization breadth elicited against the FP site of vulnerability.
A major hurdle to the development of an effective HIV-1 vaccine is the elicitation of serum responses capable of neutralizing circulating strains of HIV, which are extraordinarily diverse in sequence and often highly neutralization resistant. Recently, we showed how sera with 20 to 30% neutralization breadth could, nevertheless, be elicited in standard vaccine test animals by priming with the most prevalent N-terminal 8 residues of the HIV-1 fusion peptide (FP8), followed by boosting with a stabilized BG505-envelope (Env) trimer. Here, we show that subsequent boosting with a 3mut-apex-stabilized consensus C-Env trimer, modified to have the second most prevalent FP8 sequence, elicits higher neutralization breadth than that induced by continued boosting with the stabilized BG505-Env trimer. With increased neutralizing breadth elicited by boosting with a heterologous trimer containing the second most prevalent FP8 sequence, the fusion peptide-directed immune-focusing approach moves a step closer toward realizing an effective HIV-1 vaccine regimen.</description><identifier>ISSN: 0022-538X</identifier><identifier>ISSN: 1098-5514</identifier><identifier>EISSN: 1098-5514</identifier><identifier>DOI: 10.1128/JVI.00074-20</identifier><identifier>PMID: 32295908</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>AIDS Vaccines - immunology ; Animals ; Antibodies, Neutralizing - immunology ; env Gene Products, Human Immunodeficiency Virus - genetics ; env Gene Products, Human Immunodeficiency Virus - immunology ; Female ; Guinea Pigs ; HEK293 Cells ; HIV Antibodies - immunology ; HIV Seropositivity ; HIV-1 - immunology ; Humans ; Immunization, Secondary ; Peptides ; Vaccines and Antiviral Agents ; Vaccines, Subunit</subject><ispartof>Journal of virology, 2020-06, Vol.94 (13)</ispartof><rights>Copyright © 2020 American Society for Microbiology.</rights><rights>Copyright © 2020 American Society for Microbiology. 2020 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-9eb505d93198be1fe106026eb9cae8213290b1fc90a4badeb7d772df33f436703</citedby><cites>FETCH-LOGICAL-c411t-9eb505d93198be1fe106026eb9cae8213290b1fc90a4badeb7d772df33f436703</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307166/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307166/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,3174,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32295908$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Silvestri, Guido</contributor><creatorcontrib>Chuang, Gwo-Yu</creatorcontrib><creatorcontrib>Lai, Yen-Ting</creatorcontrib><creatorcontrib>Boyington, Jeffrey C</creatorcontrib><creatorcontrib>Cheng, Cheng</creatorcontrib><creatorcontrib>Geng, Hui</creatorcontrib><creatorcontrib>Narpala, Sandeep</creatorcontrib><creatorcontrib>Rawi, Reda</creatorcontrib><creatorcontrib>Schmidt, Stephen D</creatorcontrib><creatorcontrib>Tsybovsky, Yaroslav</creatorcontrib><creatorcontrib>Verardi, Raffaello</creatorcontrib><creatorcontrib>Xu, Kai</creatorcontrib><creatorcontrib>Yang, Yongping</creatorcontrib><creatorcontrib>Zhang, Baoshan</creatorcontrib><creatorcontrib>Chambers, Michael</creatorcontrib><creatorcontrib>Changela, Anita</creatorcontrib><creatorcontrib>Corrigan, Angela R</creatorcontrib><creatorcontrib>Kong, Rui</creatorcontrib><creatorcontrib>Olia, Adam S</creatorcontrib><creatorcontrib>Ou, Li</creatorcontrib><creatorcontrib>Sarfo, Edward K</creatorcontrib><creatorcontrib>Wang, Shuishu</creatorcontrib><creatorcontrib>Wu, Winston</creatorcontrib><creatorcontrib>Doria-Rose, Nicole A</creatorcontrib><creatorcontrib>McDermott, Adrian B</creatorcontrib><creatorcontrib>Mascola, John R</creatorcontrib><creatorcontrib>Kwong, Peter D</creatorcontrib><title>Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses</title><title>Journal of virology</title><addtitle>J Virol</addtitle><description>HIV-1 envelope (Env) trimers, stabilized in a prefusion-closed conformation, can elicit humoral responses capable of neutralizing HIV-1 strains closely matched in sequence to the immunizing strain. One strategy to increase elicited neutralization breadth involves vaccine priming of immune responses against a target site of vulnerability, followed by vaccine boosting of these responses with prefusion-closed Env trimers. This strategy has succeeded at the fusion peptide (FP) site of vulnerability in eliciting cross-clade neutralizing responses in standard vaccine-test animals. However, the breadth and potency of the elicited responses have been less than optimal. Here, we identify three mutations (3mut), Met302, Leu320, and Pro329, that stabilize the apex of the Env trimer in a prefusion-closed conformation and show antigenically, structurally, and immunogenically that combining 3mut with other approaches (e.g., repair and stabilize and glycine-helix breaking) yields well-behaved clade C-Env trimers capable of boosting the breadth of FP-directed responses. Crystal structures of these trimers confirmed prefusion-closed apexes stabilized by hydrophobic patches contributed by Met302 and Leu320, with Pro329 assuming canonically restricted dihedral angles. We substituted the N-terminal eight residues of FP (FP8, residues 512 to 519) of these trimers with the second most prevalent FP8 sequence (FP8v2, AVGLGAVF) and observed a 3mut-stabilized consensus clade C-Env trimer with FP8v2 to boost the breadth elicited in guinea pigs of FP-directed responses induced by immunogens containing the most prevalent FP8 sequence (FP8v1, AVGIGAVF). Overall, 3mut can stabilize the Env trimer apex, and the resultant apex-stabilized Env trimers can be used to expand the neutralization breadth elicited against the FP site of vulnerability.
A major hurdle to the development of an effective HIV-1 vaccine is the elicitation of serum responses capable of neutralizing circulating strains of HIV, which are extraordinarily diverse in sequence and often highly neutralization resistant. Recently, we showed how sera with 20 to 30% neutralization breadth could, nevertheless, be elicited in standard vaccine test animals by priming with the most prevalent N-terminal 8 residues of the HIV-1 fusion peptide (FP8), followed by boosting with a stabilized BG505-envelope (Env) trimer. Here, we show that subsequent boosting with a 3mut-apex-stabilized consensus C-Env trimer, modified to have the second most prevalent FP8 sequence, elicits higher neutralization breadth than that induced by continued boosting with the stabilized BG505-Env trimer. With increased neutralizing breadth elicited by boosting with a heterologous trimer containing the second most prevalent FP8 sequence, the fusion peptide-directed immune-focusing approach moves a step closer toward realizing an effective HIV-1 vaccine regimen.</description><subject>AIDS Vaccines - immunology</subject><subject>Animals</subject><subject>Antibodies, Neutralizing - immunology</subject><subject>env Gene Products, Human Immunodeficiency Virus - genetics</subject><subject>env Gene Products, Human Immunodeficiency Virus - immunology</subject><subject>Female</subject><subject>Guinea Pigs</subject><subject>HEK293 Cells</subject><subject>HIV Antibodies - immunology</subject><subject>HIV Seropositivity</subject><subject>HIV-1 - immunology</subject><subject>Humans</subject><subject>Immunization, Secondary</subject><subject>Peptides</subject><subject>Vaccines and Antiviral Agents</subject><subject>Vaccines, Subunit</subject><issn>0022-538X</issn><issn>1098-5514</issn><issn>1098-5514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpVkctuFDEQRS0EIsPAjjXykkUcyna_vEHKY0IGhYdgMrCz3O5qxqjHbtruKOR_8p_0JCGCVUlVR7du1SXkJYcDzkX15v16eQAAZcYEPCIzDqpiec6zx2QGIATLZfV9jzyL8ScAz7Iie0r2pBAqV1DNyM0JXmIX-i36RENLDZUfxsQOe7xiX5OpXeeusaELf0shXQ1uiwNdbUyii6ve-CbSs-WacfoRxzSYCTfJBU-PBjRN2tBvG_T0Ik4aq0CPQoiJno5xR3zGPrkG2Ykb0KYJWBtrnUe26Jx1u8YXjH3wEeNz8qQ1XcQX93VOLk4Xq-Mzdv7p3fL48JzZjPPEFNY55I2SXFU18hY5FCAKrJU1WAkuhYKat1aByWrTYF02ZSmaVso2k0UJck7e3un2Y73Fxk5PmU7S_XS0GX7rYJz-f-LdRv8Il7qUUPKimARe3wsM4deIMemtixa7zngMY9RCKiiyEiYvc7J_h9ohxDhg-7CGg94lq6dk9W2yWuysvfrX2gP8N0r5Bw4aoYc</recordid><startdate>20200616</startdate><enddate>20200616</enddate><creator>Chuang, Gwo-Yu</creator><creator>Lai, Yen-Ting</creator><creator>Boyington, Jeffrey C</creator><creator>Cheng, Cheng</creator><creator>Geng, Hui</creator><creator>Narpala, Sandeep</creator><creator>Rawi, Reda</creator><creator>Schmidt, Stephen D</creator><creator>Tsybovsky, Yaroslav</creator><creator>Verardi, Raffaello</creator><creator>Xu, Kai</creator><creator>Yang, Yongping</creator><creator>Zhang, Baoshan</creator><creator>Chambers, Michael</creator><creator>Changela, Anita</creator><creator>Corrigan, Angela R</creator><creator>Kong, Rui</creator><creator>Olia, Adam S</creator><creator>Ou, Li</creator><creator>Sarfo, Edward K</creator><creator>Wang, Shuishu</creator><creator>Wu, Winston</creator><creator>Doria-Rose, Nicole A</creator><creator>McDermott, Adrian B</creator><creator>Mascola, John R</creator><creator>Kwong, Peter D</creator><general>American Society for Microbiology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200616</creationdate><title>Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses</title><author>Chuang, Gwo-Yu ; Lai, Yen-Ting ; Boyington, Jeffrey C ; Cheng, Cheng ; Geng, Hui ; Narpala, Sandeep ; Rawi, Reda ; Schmidt, Stephen D ; Tsybovsky, Yaroslav ; Verardi, Raffaello ; Xu, Kai ; Yang, Yongping ; Zhang, Baoshan ; Chambers, Michael ; Changela, Anita ; Corrigan, Angela R ; Kong, Rui ; Olia, Adam S ; Ou, Li ; Sarfo, Edward K ; Wang, Shuishu ; Wu, Winston ; Doria-Rose, Nicole A ; McDermott, Adrian B ; Mascola, John R ; Kwong, Peter D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-9eb505d93198be1fe106026eb9cae8213290b1fc90a4badeb7d772df33f436703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>AIDS Vaccines - immunology</topic><topic>Animals</topic><topic>Antibodies, Neutralizing - immunology</topic><topic>env Gene Products, Human Immunodeficiency Virus - genetics</topic><topic>env Gene Products, Human Immunodeficiency Virus - immunology</topic><topic>Female</topic><topic>Guinea Pigs</topic><topic>HEK293 Cells</topic><topic>HIV Antibodies - immunology</topic><topic>HIV Seropositivity</topic><topic>HIV-1 - immunology</topic><topic>Humans</topic><topic>Immunization, Secondary</topic><topic>Peptides</topic><topic>Vaccines and Antiviral Agents</topic><topic>Vaccines, Subunit</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chuang, Gwo-Yu</creatorcontrib><creatorcontrib>Lai, Yen-Ting</creatorcontrib><creatorcontrib>Boyington, Jeffrey C</creatorcontrib><creatorcontrib>Cheng, Cheng</creatorcontrib><creatorcontrib>Geng, Hui</creatorcontrib><creatorcontrib>Narpala, Sandeep</creatorcontrib><creatorcontrib>Rawi, Reda</creatorcontrib><creatorcontrib>Schmidt, Stephen D</creatorcontrib><creatorcontrib>Tsybovsky, Yaroslav</creatorcontrib><creatorcontrib>Verardi, Raffaello</creatorcontrib><creatorcontrib>Xu, Kai</creatorcontrib><creatorcontrib>Yang, Yongping</creatorcontrib><creatorcontrib>Zhang, Baoshan</creatorcontrib><creatorcontrib>Chambers, Michael</creatorcontrib><creatorcontrib>Changela, Anita</creatorcontrib><creatorcontrib>Corrigan, Angela R</creatorcontrib><creatorcontrib>Kong, Rui</creatorcontrib><creatorcontrib>Olia, Adam S</creatorcontrib><creatorcontrib>Ou, Li</creatorcontrib><creatorcontrib>Sarfo, Edward K</creatorcontrib><creatorcontrib>Wang, Shuishu</creatorcontrib><creatorcontrib>Wu, Winston</creatorcontrib><creatorcontrib>Doria-Rose, Nicole A</creatorcontrib><creatorcontrib>McDermott, Adrian B</creatorcontrib><creatorcontrib>Mascola, John R</creatorcontrib><creatorcontrib>Kwong, Peter D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chuang, Gwo-Yu</au><au>Lai, Yen-Ting</au><au>Boyington, Jeffrey C</au><au>Cheng, Cheng</au><au>Geng, Hui</au><au>Narpala, Sandeep</au><au>Rawi, Reda</au><au>Schmidt, Stephen D</au><au>Tsybovsky, Yaroslav</au><au>Verardi, Raffaello</au><au>Xu, Kai</au><au>Yang, Yongping</au><au>Zhang, Baoshan</au><au>Chambers, Michael</au><au>Changela, Anita</au><au>Corrigan, Angela R</au><au>Kong, Rui</au><au>Olia, Adam S</au><au>Ou, Li</au><au>Sarfo, Edward K</au><au>Wang, Shuishu</au><au>Wu, Winston</au><au>Doria-Rose, Nicole A</au><au>McDermott, Adrian B</au><au>Mascola, John R</au><au>Kwong, Peter D</au><au>Silvestri, Guido</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses</atitle><jtitle>Journal of virology</jtitle><addtitle>J Virol</addtitle><date>2020-06-16</date><risdate>2020</risdate><volume>94</volume><issue>13</issue><issn>0022-538X</issn><issn>1098-5514</issn><eissn>1098-5514</eissn><abstract>HIV-1 envelope (Env) trimers, stabilized in a prefusion-closed conformation, can elicit humoral responses capable of neutralizing HIV-1 strains closely matched in sequence to the immunizing strain. One strategy to increase elicited neutralization breadth involves vaccine priming of immune responses against a target site of vulnerability, followed by vaccine boosting of these responses with prefusion-closed Env trimers. This strategy has succeeded at the fusion peptide (FP) site of vulnerability in eliciting cross-clade neutralizing responses in standard vaccine-test animals. However, the breadth and potency of the elicited responses have been less than optimal. Here, we identify three mutations (3mut), Met302, Leu320, and Pro329, that stabilize the apex of the Env trimer in a prefusion-closed conformation and show antigenically, structurally, and immunogenically that combining 3mut with other approaches (e.g., repair and stabilize and glycine-helix breaking) yields well-behaved clade C-Env trimers capable of boosting the breadth of FP-directed responses. Crystal structures of these trimers confirmed prefusion-closed apexes stabilized by hydrophobic patches contributed by Met302 and Leu320, with Pro329 assuming canonically restricted dihedral angles. We substituted the N-terminal eight residues of FP (FP8, residues 512 to 519) of these trimers with the second most prevalent FP8 sequence (FP8v2, AVGLGAVF) and observed a 3mut-stabilized consensus clade C-Env trimer with FP8v2 to boost the breadth elicited in guinea pigs of FP-directed responses induced by immunogens containing the most prevalent FP8 sequence (FP8v1, AVGIGAVF). Overall, 3mut can stabilize the Env trimer apex, and the resultant apex-stabilized Env trimers can be used to expand the neutralization breadth elicited against the FP site of vulnerability.
A major hurdle to the development of an effective HIV-1 vaccine is the elicitation of serum responses capable of neutralizing circulating strains of HIV, which are extraordinarily diverse in sequence and often highly neutralization resistant. Recently, we showed how sera with 20 to 30% neutralization breadth could, nevertheless, be elicited in standard vaccine test animals by priming with the most prevalent N-terminal 8 residues of the HIV-1 fusion peptide (FP8), followed by boosting with a stabilized BG505-envelope (Env) trimer. Here, we show that subsequent boosting with a 3mut-apex-stabilized consensus C-Env trimer, modified to have the second most prevalent FP8 sequence, elicits higher neutralization breadth than that induced by continued boosting with the stabilized BG505-Env trimer. With increased neutralizing breadth elicited by boosting with a heterologous trimer containing the second most prevalent FP8 sequence, the fusion peptide-directed immune-focusing approach moves a step closer toward realizing an effective HIV-1 vaccine regimen.</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>32295908</pmid><doi>10.1128/JVI.00074-20</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-538X |
ispartof | Journal of virology, 2020-06, Vol.94 (13) |
issn | 0022-538X 1098-5514 1098-5514 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7307166 |
source | Open Access: PubMed Central; American Society for Microbiology Journals |
subjects | AIDS Vaccines - immunology Animals Antibodies, Neutralizing - immunology env Gene Products, Human Immunodeficiency Virus - genetics env Gene Products, Human Immunodeficiency Virus - immunology Female Guinea Pigs HEK293 Cells HIV Antibodies - immunology HIV Seropositivity HIV-1 - immunology Humans Immunization, Secondary Peptides Vaccines and Antiviral Agents Vaccines, Subunit |
title | Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T05%3A04%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20a%203Mut-Apex-Stabilized%20Envelope%20Trimer%20That%20Expands%20HIV-1%20Neutralization%20Breadth%20When%20Used%20To%20Boost%20Fusion%20Peptide-Directed%20Vaccine-Elicited%20Responses&rft.jtitle=Journal%20of%20virology&rft.au=Chuang,%20Gwo-Yu&rft.date=2020-06-16&rft.volume=94&rft.issue=13&rft.issn=0022-538X&rft.eissn=1098-5514&rft_id=info:doi/10.1128/JVI.00074-20&rft_dat=%3Cproquest_pubme%3E2390647021%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c411t-9eb505d93198be1fe106026eb9cae8213290b1fc90a4badeb7d772df33f436703%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2390647021&rft_id=info:pmid/32295908&rfr_iscdi=true |